merck featured image
News Pharmaceutical & Biotech Stories

Merck Ask FDA to Authorize Antiviral COVID-19 Pill

Monday, October 11, The pharmaceutical giant Merck & Co. asked U.S. regulators to authorize its pill for treating COVID-19.

The drugmaker had asked the U.S. FDA to grant emergency use authorization to its experimental COVID-19 antiviral drug treatment— molnupiravir— an oral medication that could be promising in the global fight against the coronavirus pandemic.

In a news release, Merck and its partner Ridgeback Biotherapeutics said that, in addition to their FDA application, they plan to apply for emergency use or marketing authorization in other countries “in the coming months.”

Early trials of the drug showed significant promise in reducing the risk of hospitalization and death among at-risk patients with mild to moderate cases of COVID-19, which could be an especially important tool in poor countries, where vaccine supply is low.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS